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| INTRODUC TI ON
Glycoprotein NMB is a type IA transmembrane protein that is highly expressed in many types of cancers, including melanoma, glioblastoma, and breast cancer. It is considered a poor prognostic factor in those cancers and it might be an attractive therapeutic target. [1] [2] [3] [4] [5] We have previously reported that enhanced expression of GPNMB induces EMT and increases sphere formation in vitro and tumor growth in vivo, whereas knockdown of GPNMB attenuated the tumorigenic ability of breast cancer cells. 6 We also showed that cell surface expression of GPNMB is induced in limited numbers of breast cancer cells in sphere-culture conditions in vitro and in growing tumors in vivo and induces stem-like properties, such as high expression of stemness genes, low expression of proliferation genes, and high sphere and tumor formation. 7 These functions depend on the tyrosine residue of the hemITAM in the ICD of GPNMB. 6, 7 In addition, Lin et al 8 reported
that GPNMB interacts with epidermal growth factor receptor and that stimulation of heparin-binding EGF triggers the phosphorylation of the tyrosine residue in hemITAM. They also showed the significance of tyrosine phosphorylation in the poorer prognosis of breast cancer patients. These findings together with ours suggest that both the ICD and the ECD are essential for the tumorigenic function of GPNMB;
however, the function of the ECD has yet to be fully elucidated.
Glycoprotein NMB consists of a long ECD that contains an N-terminal signal peptide, an RGD motif, a PKD domain, and a KLD, a singlepass transmembrane domain, and a short ICD that harbors a hemITAM and a dileucine motif. 2, [9] [10] [11] The RGD motif is known as an integrin-binding sequence and has been shown to be involved in the migratory activity of breast cancer cells 12 and cell-cell adhesion. 13, 14 Glycoprotein NMB interacts with syndecan-4, which is expressed on the surface of T cells, through the PKD, and this interaction suppresses T-cell activation and proliferation. [15] [16] [17] [18] [19] So far, little is known about the function of the KLD in GPNMB. Therefore, in the present study, we clarified the contribution of the KLD to the tumorigenic function of GPNMB.
| MATERIAL S AND ME THODS

| Cells and cell culture
293T cells and NMuMG cells were obtained from the ATCC. We cultured these cells in DMEM (Sigma-Aldrich) supplemented with 10% FBS, 100 units/mL penicillin G, and 0.1 mg/mL of streptomycin sulfate (Wako Pure Chemical Industries). NMuMG cells stably expressing GPNMB, both WT and KLD-deletion mutant (ΔKLD),
were maintained in the presence of puromycin (1 μg/mL; SigmaAldrich). 6 L Wnt-3A cells and L cells (ATCC) were used to prepare
Wnt3A conditioned medium and control medium as described previously. 20 
| DNA constructs and transfection
Glycoprotein NMB and Src cDNA were cloned previously, 6 and GPNMB(ΔKLD) lacking amino acids 420-491 of mouse GPNMB was generated by PCR, followed by cloning into pCAGIP-or pcDEF3-expressing vectors. pCAG-GS-β-catenin and TOP-flash luciferase reporter were described previously. 20 These constructs were transfected into cells by use of PEI Max (Polysciences). To establish stably expressing cell lines, NMuMG cells were transfected using Lipofectamine 3000 (Invitrogen) as described previously.
6,21
| Immunoprecipitation
For the immunoprecipitation, 293T cells were transfected with the indicated plasmids, and the cells were then solubilized in lysis buffer (20 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 1% Nonidet P-40, 2000 kIU/mL aprotinin, and 1 μg/mL leupeptin). The debris was then precipitated by centrifugation; a small amount of total cell lysates was collected and the remainder was used for immunoprecipitation with anti-FLAG Ab (M2; Sigma-Aldrich).
| Sodium dodecyl sulfate-PAGE and immunoblot analysis
The protein samples were subjected to SDS-PAGE. The proteins were then electrotransferred to PVDF membranes (Millipore) and subjected to immunoblot analysis. Antibodies against FLAG (M2; Sigma-Aldrich), HA (3F10; Roche Diagnostics), c-Myc (9E10; Santa Cruz Biotechnology), and phosphorylated tyrosine (4G10; Millipore) were used. The reacted Abs were detected as described previously. 
| Reverse transcription-PCR and quantitative real-time PCR
Reverse transcription-PCR (RT-PCR) was carried out as described previously. 23 In brief, total RNA was extracted using ISOGEN II reagent (Nippon Gene). Reverse transcription was undertaken using High Capacity RNA-to-cDNA Master Mix (Applied Biosystems) and semiquantitative RT-PCR was carried out with the previously described specific primers 6 and using Ex Taq polymerase (Takara). Real-Time PCR was performed using GeneAce SYBR quantitative real-time PCR (qPCR) mix α Low ROX (Nippon Gene) and the ABI7500 Fast Sequence Detection system (Applied Biosystems). All samples were run in triplicate in each experiment. Primer sequences are as follows:
mouse Axin2 forward, 5′-TGACTCTCCTTCCAGATCCCA-3′, and reverse 5′-TGCCCACACTAGGCTGACA-3′); and mouse β-actin forward, 5′-CGATGCCCTGAGGCTCTTT-3′, and reverse 5′-TGGATGCCACAGGATTCCA-3′. 
| Sphere formation
| Tumor formation
| Immunofluorescence staining
The cells were fixed in 4% paraformaldehyde. After fixation, we Molecular Probes). TO-PRO3 (Thermo Fisher Scientific) was used for nuclear staining. For the actin staining, fluorescein phalloidin (Molecular Probes) was used. A confocal laser-scanning microscope, the TCS SP8 (Leica Microsystems), was used for the detection and image taking.
| Immunohistochemical staining
The 
| Transmission electron microscopy
| Sequence alignment
| Luciferase reporter assay
Cells were transfected with the TOP-flash firefly luciferase reporter and pRL-CMV Renilla luciferase reporter. Luciferase activity in cell lysates was determined by a Luciferase reporter assay system (Promega) using a luminometer (MicroLumat). Luciferase activities were normalized to corresponding Renilla luciferase activity.
| Statistical analysis
Quantitative data are expressed as mean ± SD. The statistical analyses were undertaken using 1-way ANOVA with the Tukey multiple comparison test with GraphPad Prism 7 software (GraphPad) or Student's t test with Excel (Microsoft). Probability values <0.05 were considered significant.
| RE SULTS
| Glycoprotein NMB has a KLD that is conserved across species
To identify the important region in the ECD of GPNMB in terms of its tumorigenic potential, we reviewed its motif and domain structures ( Figure 1A) . Among all the known motifs and domains in the ECD, little is known about the function of the KLD, although the KLD of PMEL, a GPNMB homologous protein, promotes amyloid formation by facilitating PMEL oligomerization. 24 In general, a KD contains 80 amino acids and its typical loop structures are formed by 3 intramolecular disulfide bonds. 24 We first examined the conservation of the KLD among species and found that the KLD of GPNMB is highly conserved across species, including the 6 cysteines that are important in the disulfide bond formation in the KD ( Figure 1B ).
| Deletion of the KLD does not affect GPNMB subcellular localization, tyrosine phosphorylation, or homo-oligomer formation
To investigate the function of the KLD in GPNMB, we constructed a deletion mutant of mouse GPNMB, GPNMB(ΔKLD) in which amino acids 420-491 are deleted (Figure 2A ). After cloning into mammalian expressing vectors, we confirmed its expression in 293T cells ( Figure 2B ). In addition, flow cytometry analysis revealed that both GPNMB(WT) and GPNMB(ΔKLD) proteins were similarly expressed on the surface of 293T cells when we transiently overexpressed them ( Figure 2C ). We next established stably expressing cell lines of either GPNMB(WT) or GPNMB(ΔKLD) using NMuMG cells: NMuMG-GPNMB(WT) clone 3 and clone 8
(here called G3 and G8 6 ) and NMuMG-GPNMB(ΔKLD) clone 7
and clone 11 (here called ΔKLD7 and ΔKLD11) ( Figure 2D ). We next undertook immunofluorescence staining to examine the subcellular localization. GPNMB(ΔKLD) colocalized mainly with an endosome marker, EEA1, and a lysosome marker, LAMP1, as did GPNMB(WT) ( Figure 2E ), indicating that deletion of KLD does not affect its subcellular localization. Next, we evaluated the tyrosine phosphorylation by Src because our previous study showed that GPNMB was phosphorylated by Src on the tyrosine residue in its hemITAM. 6 As shown in Figure 2F , the deletion of KLD did not influence the phosphorylation of GPNMB, at least by coexpressed Src in 293T cells. We also found that GPNMB could form a homooligomer. Therefore, we investigated whether GPNMB(ΔKLD) can also make a homo-oligomer. Immunoprecipitation-immunoblot analysis showed that KLD is not responsible for the oligomer formation ( Figure 2G ). Although deletion of the whole domain sometimes results in a nonfunctional protein, these results suggest that the deletion of the KLD does not affect the basic properties of GPNMB, such as subcellular localization, tyrosine phosphorylation, and homo-oligomer formation. Therefore, we continued to investigate the tumorigenic functions of GPNMB(ΔKLD). 
| Kringle-like domain is important in GPNMBinduced tumorigenic potential
To investigate the importance of the KLD in GPNMB-induced tumorigenic growth, we undertook assays of in vitro sphere formation and in vivo tumor formation. GPNMB(ΔKLD)-expressing cells showed significantly lower sphere-forming activity than that of GPNMB(WT)-expressing cells ( Figure 3A , Table S1 ). When we injected cells of either NMuMG-GPNMB(WT) or NMuMG-GPNMB(ΔKLD) s.c. into nude mice, the tumors from the GPNMB(ΔKLD)-expressing cells were significantly smaller and had a lower incidence than those from the GPNMB(WT) cells ( Figure 3B ,C, Table S2 ). These results indicate the essential contribution of the KLD to GPNMB-induced tumorigenic growth in both in vitro and in vivo systems.
| Deletion of the KLD partially maintains cellular junctions and polarity
We next analyzed each tumor histologically. On H&E staining, tubular structures were observed in the tissue of the NMuMG-mock cells, suggesting their epithelial feature. In contrast, the tumor of
NMuMG-GPNMB(WT) cells consisted of mesenchyme-like cells and no
tubule-like structures were seen, as we already reported. 6 To our surprise, To examine the cellular junction formation, we used transmission electron microscopy observation to compare the GPNMB(WT) and ) is an endosomal marker and lysosome-associated membrane protein 1 (LAMP1; red) is a lysosomal marker. Scale bar, 20 μm. F,G, Tyrosine phosphorylation and oligomer formation of GPNMB. 293T cells were transfected with the indicated plasmids, and immunoprecipitation (IP) was carried out using anti-FLAG Ab, followed by immunoblot (IB) analysis with anti-phosphorylated tyrosine (4G10), anti-FLAG, and anti-Myc Abs to detect Src-induced tyrosine phosphorylation of GPNMB (F), and with anti-His and anti-FLAG Abs to detect oligomer formation of GPNMB (G)
F I G U R E 2 Deletion of the kringle-like domain (KLD) from glycoprotein NMB (GPNMB) does not affect its basic properties. A, 2D scheme of mouse WT GPNMB, and a KLD deletion mutant (ΔKLD). TM, transmembrane domain. B, Exogenous expression of GPNMB(WT) and GPNMB(ΔKLD) in 293T cells. 293T cells were transfected with pCAGIP-GPNMB(WT)-FLAG/HA or pCAGIP-GPNMB(ΔKLD)-FLAG/HA, and immunoblot analysis for FLAG was carried out to detect GPNMB(WT) and GPNMB(ΔKLD
F I G U R E 3 Deletion of the kringle-like domain (KLD) attenuates the tumorigenic ability of glycoprotein NMB (GPNMB).
A, Sphereforming abilities of NMuMG-mock, NMuMG-GPNMB(WT) (G3 and G8), and NMuMG-GPNMB(ΔKLD) (∆K7 and ∆K11) cells were examined. Only spheres larger than 50 μm in diameter were counted. Data are presented as mean ± SD; n = 3 replicates, representative of 3 independent experiments. **P < 0.01, ****P < 0.0001 (vs mock), # P < 0.05, #### P < 0.0001 (vs G3 and G8), 1-way ANOVA with Tukey multiple comparison test. B,C, Tumor growth abilities of NMuMG-mock, NMuMG-GPNMB(WT) (G8), and NMuMG-GPNMB(ΔKLD) (∆K7 and ∆K11) cells examined by s.c. injection into ICR-nu/nu mice. Macroscopic view (B) and measured volumes (C). Data are presented as mean ± SD; n = 5 mice. ****P < 0.0001 (vs mock), #### P < 0.0001 (vs G8), 1-way ANOVA with Tukey multiple comparison test GPNMB(ΔKLD) grafts with the mock grafts. Tight junctions were observed in the mock grafts, whereas none could be observed in the GPNMB(WT) grafts; in addition, no villi could be observed in the GPNMB(WT) grafts, indicating loss of the epithelial feature.
However, the GPNMB(ΔKLD) tumors seemed to have tight junctionlike adhesion structures, whereas the GPNMB(WT) tumors did not ( Figure 4E ). In other words, GPNMB(ΔKLD) had less disruption of cell polarity, despite not having E-cadherin and mature tight junctions.
| Deletion of the KLD maintains the GPNMB function to suppress E-cadherin expression but impairs its function to activate cellular migration and Wnt/β-catenin signaling
We further examined the phenotypes of GPNMB(ΔKLD) cells in terms of the induction of EMT. Previously, we reported that enhanced expression of GPNMB(WT) induces EMT phenotypes in NMuMG cells, such as downregulation of E-cadherin, promotion of cellular migration and invasion, and induction of stem-like properties in breast cancer cells. 6, 7 As shown in Figure 5A and 5B, GPNMB(ΔKLD) induced suppression of E-cadherin, as did GPNMB(WT). However, when we investigated the actin fiber structures, GPNMB(WT) activated stress fiber formation, whereas GPNMB(ΔKLD) retained the cortical actin fibers ( Figure 5C ). Furthermore, a Transwell migration assay indicated that GPNMB(ΔKLD) lacked the cell migration-promoting effect ( Figure 5D , Table S3 ). Taken together, these findings indicate that the deletion of the KLD from GPNMB could impair GPNMB-induced motility even if suppression of E-cadherin was observed by stable expression of GPNMB(ΔKLD) in NMuMG cells. The molecular mechanism that explains how deletion of the KLD partially impairs EMT and the cell migration-inducing activity of GPNMB has not been fully elucidated yet, but our preliminary examination indicated the impairment F I G U R E 4 Deletion of the kringlelike domain partially maintains cellular junctions and polarity. A-D, Histology of the xenograft tumors shown in Figure  3C was determined by H&E staining (A) and immunohistochemical staining for HA (B), E-cadherin (C), and Ki-67 (D). Scale bar, 50 μm. E, Transmission electron microscopic images of the xenografts of NMuMG-mock, NMuMG-GPNMB(WT) (G8), and NMuMG-GPNMB(ΔKLD) (∆K7 and ∆K11) cells as indicated. Arrow, microvilli; black arrowhead, tight junction structure; red arrowhead, tight junctionlike structure of Wnt/β-catenin signaling detected by TOP-flash reporter assay and Axin2 mRNA levels ( Figure 5E,F) . Therefore, supportive effects on Wnt signaling are a possible molecular function of GPNMB KLD.
| D ISCUSS I ON
This is the first report to identify the importance of the region of amino We previously reported that expression of GPNMB(WT) fully induces EMT in NMuMG cells. 6 In the current study, we have confirmed that overexpression of GPNMB(ΔKLD) suppressed E-cadherin expression at both the mRNA and the protein levels, as well as GPNMB(WT) did ( Figure 5A,B) . In contrast, GPNMB(ΔKLD) did not induce stress fiber formation nor cell migration ( Figure 5C ,D).
Epithelial-mesenchymal transition is a biological process that allows epithelial cells to harbor mesenchymal phenotypes, which activates cell migration, invasiveness, and resistance to apoptosis, and also contributes to induction of stem-like properties. [25] [26] [27] During EMT, dissolution of adherence junction proteins and disruption of the tight junctions lead the cells to lose their cell-cell adhesion and apical-basal polarity, and thus, they become migratory and invasive.
However, sometimes it is not easy to divide cancer cells into cells with only epithelial or mesenchymal features, and cells with both epithelial and mesenchymal phenotypes have recently been reported, which is termed partial EMT. 28, 29 Although the phenotypes of NMuMG-GPNMB(ΔKLD) are different from those of complete
Deletion of the kringle-like domain (KLD) maintains the glycoprotein NMB (GPNMB) function to suppress E-cadherin expression but impairs its function to activate cellular migration and Wnt/β-catenin signaling. A,B, Expressions of GPNMB, E-cadherin, and β-actin in NMuMG-mock, NMuMG-GPNMB(WT) (G3 and G8), and GPNMB(ΔKLD) (∆K7 and ∆K11) cells were examined by RT-PCR for mRNA (A) and by immunoblot analysis for proteins (B). C, Immunofluorescence staining showing stress fiber formation in NMuMG-mock, NMuMG-GPNMB(WT) (G3 and G8), and NMuMG-GPNMB(ΔKLD) (∆K7 and ∆K11) cells. Actin (green) was stained using phalloidin (green), and TO-PRO3 (magenta) was used to indicate the nuclei. Scale bar, 20 μm. D, Migration of NMuMG-mock and NMuMG-GPNMB(WT) (G3 and G8), and NMuMG-GPNMB(ΔKLD) (∆K7 and ∆K11) cells was examined by Transwell migration assay. Data are presented as mean ± SD; n = 3 replicates, representative of 3 independent experiments. ****P < 0.0001 (vs mock), ####P < 0.0001 (vs G3 and G8), 1-way ANOVA with Tukey multiple comparison test. Scale bar, 200 μm. E,F, Effects of GPNMB(WT) and GPNMB(DKLD) on Wnt/β-catenin signaling. NMuMG-mock and NMuMG-GPNMB(WT) G8 and NMuMG -GPNMB(ΔKLD) ΔK7 cells were transfected with TOP-flash firefly luciferase reporter and pRL-CMV Renilla luciferase reporter with/without pCAG-GS-β-catenin expressing vectors. Data are presented as mean ± SD; n = 3. **P < 0.01, Student's t test. ns, not significant (E). NMuMG-mock and NMuMG-GPNMB(WT) G8 and NMuMG-GPNMB(ΔKLD) ΔK7 cells were treated with Wnt3A conditioned medium or control medium for 3 h and Axin-2 mRNA was measured by quantitative PCR and normalized to β-actin expression levels. Data are presented as mean ± SD; n = 3. ***P < 0.001, Student's t test (F)
EMT and partial EMT, it might be a kind of intermediate phenotype between epithelial and mesenchymal, resulting in fewer migratory and tumorigenic abilities.
The point mutant in which the tyrosine residue in hemITAM was altered to phenylalanine, GPNMB(YF), totally lost EMT and stemlike properties inducing activity. 6,7 GPNMB(YF) did not suppress E-cadherin and lacked the promoting effect on cellular migration and sphere and tumor formation, 6 indicating the crucial role of the tyrosine residue in the tumorigenic ability of GPNMB. However, deletion of the KLD impaired the tumorigenic potential, although GPNMB(ΔKLD) could be phosphorylated by Src when we transiently overexpressed both of them ( Figure 2F ). Phosphorylation of endogenous GPNMB hemITAM tyrosine in sphere or in tumor could not be directly detected; however, our previous and current findings suggest that this tyrosine phosphorylation is crucial, and additional mechanisms through KLD could be working to fully trigger the tumorigenic function of GPNMB.
The KD is composed of 80 amino acids and 3 intramolecular disulfide bonds to make a typical loop structure. It is thought to be involved in the interactions of proteins, lipids, and small molecules. 30 It is found in proteins such as coagulation factors (prothrombin and coagulation factor XII), 31 proteases (urokinase, plasminogen, plasminogen activator, and serine proteases), 31 growth factors (hepatocyte growth factor), 32 and receptors (RORs and MuSK). 33, 34 Both RORs and MuSK contain KD and cysteine rich domain, which is thought to be responsible for Wnt ligand binding, in their ECD. Wnt5A induces ROR1 and ROR2 heterodimerization through KD, and activates chemotaxis and proliferation of leukemia cells. 35 Additionally,
MuSK is also involved in the noncanonical Wnt signaling pathway. 36 Recent publications, however, showed that GPNMB is involved in Wnt/β-catenin signaling in glioma, cervical cancer, and breast cancer models. [37] [38] [39] These findings bring us one possibility that the KLD of GPNMB is somehow involved in the Wnt signaling pathway and our initial experiments suggested that GPNMB KLD might have some function to support Wnt/β-catenin signaling ( Figure 5E,F) . Further studies are needed to reveal the mechanism by which the KLD contributes to the tumorigenic function of GPNMB, and identification of the binding partner through this region is essential. The Wnt/ PCP pathway must be the focus in studies of the phenotype of GPNMB(ΔKLD) cell tumors in the future.
Glembatumumab vedotin, or CDX-011, an Ab against GPNMB conjugated with an anticancer drug, has been developed to treat GPNMB-expressing cancers and is in clinical trials for breast cancer and melanoma patients. 5, [40] [41] [42] [43] This suggests the potential of GPNMB as a therapeutic target. From the findings of this study, we propose that specifically targeting the KLD in the ECD of GPNMB is a possible therapeutic target.
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